Na Cai Selected Research

Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)

1/2021	An Aptamer-Based Antagonist against the Receptor for Advanced Glycation End-Products (RAGE) Blocks Development of Colorectal Cancer.
1/2017	Celecoxib Down-Regulates the Hypoxia-Induced Expression of HIF-1α and VEGF Through the PI3K/AKT Pathway in Retinal Pigment Epithelial Cells.
1/2017	Anti-angiogenic effect of rapamycin in mouse oxygen-induced retinopathy is mediated through suppression of HIF-1alpha/VEGF pathway.
6/2015	Suppression of the proliferation of hypoxia-Induced retinal pigment epithelial cell by rapamycin through the /mTOR/HIF-1α/VEGF/ signaling.
1/2015	Celecoxib attenuates retinal angiogenesis in a mouse model of oxygen-induced retinopathy.
1/2012	Expressions of survivin and vascular endothelial growth factor in a Murine model of proliferative retinopathy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Na Cai Research Topics

Disease

8	Neoplasms (Cancer) 03/2024 - 05/2014
6	Hypoxia (Hypoxemia) 01/2017 - 01/2015
5	Hepatocellular Carcinoma (Hepatoma) 05/2014 - 11/2005
4	Necrotizing Enterocolitis 02/2024 - 01/2016
3	Kidney Diseases (Kidney Disease) 02/2024 - 01/2014
3	Diabetic Retinopathy (Retinopathy, Diabetic) 01/2022 - 01/2015
3	Major Depressive Disorder (Major Depressive Disorders) 01/2020 - 12/2015
3	Neoplasm Metastasis (Metastasis) 07/2016 - 01/2016
2	Sepsis (Septicemia) 02/2024 - 09/2020
2	Macular Edema 01/2022 - 06/2020
2	Hemorrhage 06/2020 - 01/2016
2	Phenylketonurias (Phenylketonuria) 11/2017 - 02/2014
2	Retinal Neovascularization 01/2017 - 01/2012
2	Retinopathy of Prematurity (Retrolental Fibroplasia) 01/2016 - 01/2012
2	Carcinogenesis 01/2016 - 11/2005
2	Carcinoma (Carcinomatosis) 01/2016 - 01/2013
1	Acute Kidney Injury (Acute Renal Failure) 02/2024
1	Congenital Adrenal Hyperplasia (Hyperplasia, Congenital Adrenal) 01/2024
1	Fever (Fevers) 01/2023
1	Osteoporosis 06/2022
1	Newborn Respiratory Distress Syndrome 04/2022
1	Hypoproteinemia 01/2022
1	Mental Disorders (Mental Disorder) 01/2022
1	Hydronephrosis 05/2021
1	Colorectal Neoplasms (Colorectal Cancer) 01/2021
1	Inflammation (Inflammations) 01/2021
1	Intraoperative Complications 06/2020
1	Retinal Perforations 06/2020
1	Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder) 01/2020
1	Lissencephaly 01/2018
1	Reperfusion Injury 12/2017
1	Myocardial Ischemia (Ischemic Heart Diseases) 12/2017
1	Hypersensitivity (Allergy) 07/2017
1	Trisomy 13 Syndrome 05/2017
1	Aneuploidy (Aneuploid) 05/2017
1	Down Syndrome (Down's Syndrome) 05/2017
1	Dysthymic Disorder 11/2016
1	Osteosarcoma (Osteogenic Sarcoma) 01/2016
1	Birth Weight (Birth Weights) 01/2016
1	Chromosome Breakage 01/2016

Drug/Important Bio-Agent (IBA)

9	Proteins (Proteins, Gene)FDA Link 01/2017 - 08/2009
6	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2021 - 01/2012
5	SurvivinIBA 01/2015 - 11/2005
4	Retinaldehyde (Retinal)IBA 01/2017 - 01/2012
3	Hemoglobins (Hemoglobin)IBA 02/2024 - 09/2020
3	Mitochondrial DNA (mtDNA)IBA 01/2020 - 12/2015
3	Celecoxib (Celebrex)FDA Link 01/2017 - 01/2015
2	Plant ExtractsIBA 02/2024 - 12/2023
2	aristolochic acid I (aristolochic acid)IBA 02/2024 - 12/2023
2	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2024 - 04/2014
2	ProcalcitoninIBA 01/2023 - 01/2022
2	dichlorobis(azomycin)platinum IIIBA 05/2021 - 05/2017
2	CateninsIBA 01/2018 - 01/2016
2	Phenylalanine Hydroxylase (Phenylalanine 4 Monooxygenase)IBA 11/2017 - 02/2014
2	Retinal Pigments (Pigments, Visual)IBA 01/2017 - 06/2015
2	Sirolimus (Rapamycin)FDA Link 01/2017 - 06/2015
2	Messenger RNA (mRNA)IBA 01/2017 - 01/2015
2	TOR Serine-Threonine KinasesIBA 01/2017 - 06/2015
2	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 01/2017 - 01/2015
2	DNA (Deoxyribonucleic Acid)IBA 01/2016 - 09/2012
2	Transcription Factors (Transcription Factor)IBA 01/2016 - 01/2015
2	hepatitis B virus X proteinIBA 01/2008 - 11/2005
1	Benzene (Benzole)IBA 03/2024
1	C-Reactive ProteinIBA 01/2023
1	CalciumIBA 01/2023
1	Creatine Kinase (Creatine Phosphokinase)IBA 01/2023
1	SodiumIBA 01/2023
1	QuercetinIBA 06/2022
1	KH902 fusion proteinIBA 01/2022
1	Advanced Glycation End ProductsIBA 01/2021
1	APTIBA 01/2021
1	Receptor for Advanced Glycation End ProductsIBA 01/2021
1	Silicone OilsIBA 06/2020
1	Ranibizumab (Lucentis)FDA Link 06/2020
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2019
1	CopperIBA 01/2019
1	pterostilbeneIBA 12/2017
1	Phosphatidylinositols (Phosphatidylinositol)IBA 12/2017
1	Phosphotransferases (Kinase)IBA 12/2017
1	Deoxyribonuclease I (Nickase)IBA 07/2017
1	Endothelial Growth FactorsIBA 01/2017
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 07/2016
1	Auranofin (Ridaura)FDA Link 01/2016
1	Biomarkers (Surrogate Marker)IBA 01/2016
1	Histone MethyltransferasesIBA 01/2016
1	Glutathione Transferase (Glutathione S-Transferase)IBA 01/2016
1	Lysine (L-Lysine)FDA Link 01/2016
1	Histones (Histone)IBA 01/2016
1	Protein Kinase CIBA 12/2015

Therapy/Procedure

2	Continuous Positive Airway Pressure 04/2022 - 12/2012
2	Therapeutics 01/2021 - 04/2014
1	Cannula 04/2022
1	Light Coagulation 01/2022
1	Erythrocyte Transfusion 01/2022
1	Precision Medicine 01/2022
1	Vitrectomy 06/2020
1	Operative Time 06/2020
1	Enteral Nutrition (Feeding, Tube) 01/2016
1	Aftercare (After-Treatment) 01/2016
1	Mechanical Ventilators (Ventilator) 01/2016